Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability.

Onoue S, Suzuki H, Kojo Y, Matsunaga S, Sato H, Mizumoto T, Yuminoki K, Hashimoto N, Yamada S.

Eur J Pharm Sci. 2014 Oct 1;62:16-22. doi: 10.1016/j.ejps.2014.05.006. Epub 2014 May 14.

PMID:
24836392
[PubMed - in process]
2.

Development of novel solid dispersion of tranilast using amphiphilic block copolymer for improved oral bioavailability.

Onoue S, Kojo Y, Suzuki H, Yuminoki K, Kou K, Kawabata Y, Yamauchi Y, Hashimoto N, Yamada S.

Int J Pharm. 2013 Aug 16;452(1-2):220-6. doi: 10.1016/j.ijpharm.2013.05.022. Epub 2013 May 18.

PMID:
23694807
[PubMed - indexed for MEDLINE]
3.

Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.

Onoue S, Sato H, Ogawa K, Kawabata Y, Mizumoto T, Yuminoki K, Hashimoto N, Yamada S.

Int J Pharm. 2010 Oct 31;399(1-2):94-101. doi: 10.1016/j.ijpharm.2010.08.007. Epub 2010 Aug 10.

PMID:
20705124
[PubMed - indexed for MEDLINE]
4.

Comparative studies on physicochemical stability of cyclosporine A-loaded amorphous solid dispersions.

Sato H, Kawabata Y, Yuminoki K, Hashimoto N, Yamauchi Y, Ogawa K, Mizumoto T, Yamada S, Onoue S.

Int J Pharm. 2012 Apr 15;426(1-2):302-6. doi: 10.1016/j.ijpharm.2012.01.022. Epub 2012 Jan 20.

PMID:
22285473
[PubMed - indexed for MEDLINE]
5.

Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wet-milling system.

Onoue S, Terasawa N, Nakamura T, Yuminoki K, Hashimoto N, Yamada S.

Eur J Pharm Sci. 2014 Mar 12;53:118-25. doi: 10.1016/j.ejps.2013.12.013. Epub 2013 Dec 22.

PMID:
24368114
[PubMed - in process]
6.

Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.

Onoue S, Nakamura T, Uchida A, Ogawa K, Yuminoki K, Hashimoto N, Hiza A, Tsukaguchi Y, Asakawa T, Kan T, Yamada S.

Eur J Pharm Sci. 2013 Jul 16;49(4):453-60. doi: 10.1016/j.ejps.2013.05.014. Epub 2013 May 24.

PMID:
23707470
[PubMed - indexed for MEDLINE]
7.

In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy.

Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S.

J Control Release. 2009 Aug 19;138(1):16-23. doi: 10.1016/j.jconrel.2009.04.014. Epub 2009 Apr 17.

PMID:
19376169
[PubMed - indexed for MEDLINE]
8.

Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.

Onoue S, Sato H, Ogawa K, Kojo Y, Aoki Y, Kawabata Y, Wada K, Mizumoto T, Yamada S.

Eur J Pharm Biopharm. 2012 Jan;80(1):54-60. doi: 10.1016/j.ejpb.2011.10.003. Epub 2011 Oct 8.

PMID:
22008148
[PubMed - indexed for MEDLINE]
9.

Development of high-energy amorphous solid dispersion of nanosized nobiletin, a citrus polymethoxylated flavone, with improved oral bioavailability.

Onoue S, Uchida A, Takahashi H, Seto Y, Kawabata Y, Ogawa K, Yuminoki K, Hashimoto N, Yamada S.

J Pharm Sci. 2011 Sep;100(9):3793-801. doi: 10.1002/jps.22585. Epub 2011 Apr 24.

PMID:
21520087
[PubMed - indexed for MEDLINE]
10.

Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.

Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S.

Drug Metab Pharmacokinet. 2012;27(4):379-87. Epub 2012 Jan 13.

PMID:
22240843
[PubMed - indexed for MEDLINE]
Free Article
11.

Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability.

Kawabata Y, Yamamoto K, Debari K, Onoue S, Yamada S.

Eur J Pharm Sci. 2010 Feb 19;39(4):256-62. doi: 10.1016/j.ejps.2009.12.009. Epub 2009 Dec 28.

PMID:
20038453
[PubMed - indexed for MEDLINE]
12.

Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres.

Lee EJ, Lee SW, Choi HG, Kim CK.

Int J Pharm. 2001 May 7;218(1-2):125-31.

PMID:
11337156
[PubMed - indexed for MEDLINE]
13.
14.

In vitro/in vivo characterization of nanocrystalline formulation of tranilast with improved dissolution and hepatoprotective properties.

Onoue S, Yamamoto K, Kawabata Y, Yamada S.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):952-7. doi: 10.1016/j.ejpb.2013.09.003. Epub 2013 Sep 18.

PMID:
24055688
[PubMed - in process]
15.

Solid self-nanoemulsifying cyclosporine A pellets prepared by fluid-bed coating: stability and bioavailability study.

Lei Y, Qi J, Nie S, Hu F, Pan W, Lu Y, Wu W.

J Biomed Nanotechnol. 2012 Jun;8(3):515-21.

PMID:
22764422
[PubMed - indexed for MEDLINE]
16.

Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy.

Sato H, Ogawa K, Kojo Y, Kawabata Y, Mizumoto T, Yamada S, Onoue S.

Int J Pharm. 2013 May 1;448(1):282-9. doi: 10.1016/j.ijpharm.2013.03.026. Epub 2013 Mar 22.

PMID:
23528280
[PubMed - indexed for MEDLINE]
17.

Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.

Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, Yamada S.

J Pharm Sci. 2010 Apr;99(4):1871-81. doi: 10.1002/jps.21964.

PMID:
19827133
[PubMed - indexed for MEDLINE]
18.

Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.

Nielsen LH, Gordon S, Holm R, Selen A, Rades T, M├╝llertz A.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.

PMID:
24075980
[PubMed - in process]
19.

Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).

Kang JH, Oh DH, Oh YK, Yong CS, Choi HG.

Eur J Pharm Biopharm. 2012 Feb;80(2):289-97. doi: 10.1016/j.ejpb.2011.11.005. Epub 2011 Nov 18.

PMID:
22119666
[PubMed - indexed for MEDLINE]
20.

Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations.

Law D, Schmitt EA, Marsh KC, Everitt EA, Wang W, Fort JJ, Krill SL, Qiu Y.

J Pharm Sci. 2004 Mar;93(3):563-70.

PMID:
14762895
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk